CRVS vs WEC · $1.04B cap vs P/E 23, rev $5.50B
Corvus Pharmaceuticals Inc (CRVS) versus WEC Energy Group Inc (WEC) — a side-by-side from cached financials, not a winner call.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
WEC Energy Group Inc (WEC) is a utilities - regulated electric company listed on NYSE.
CRVS does not have a complete income-statement cache yet.
Latest reported WEC revenue for 2026-06-30 was $5.50B. Net income was $1.11B. Revenue was up 60.0% from 2026-03-31 to 2026-06-30. WEC currently screens at market cap $36.66B and trailing P/E 22.6.
CRVS currently screens at market cap $1.04B. WEC currently screens at market cap $36.66B and trailing P/E 22.6.
Not investment advice. Open the CRVS and WEC stock pages for the full models.
Not investment advice.